ARTAN Bio
PrivateLast Round
Seed
Jun 4, 2026
Total Funding Raised
$291,300
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ARTAN Bio is a biotechnology company developing a novel engineered suppressor tRNA system to address genetic and age-related diseases caused by nonsense mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, DAOs, Tokenization
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTAN Bio Comparables
Compare ARTAN Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tevard Biosciences | 88% | |
| Alltrna | 86% | |
| Codone Biotechnology | 85% | |
ARTAN Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 4, 2026 | ||||
| Pre Seed | Aug 2, 2023 |
ARTAN Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VitaDAO | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$200K round with participation from VitaDAO.
ARTAN Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARTAN Bio's valuation, stock price, and market status.